Insights Center

Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.

Featured

Mintz Direct

On our new Mintz Direct page, Mintz thought leaders across industries and practice areas offer timely insights on developments that impact our clients and communities. Visit the Mintz Direct page to hear what our experienced attorneys and professionals are saying about what’s happening now.

Mintz Viewpoints

Use quotation marks to search for an exact phrase (e.g. “class action”)

Published

Showing 6761 - 6768 of 12099 results

MintzTech Innovator Profile: quip

September 15, 2017| Article| Viewpoint

MSRB Addresses Selective Disclosure

September 15, 2017| Blog| Viewpoint

Have you started auditing your contracts with your service providers that handle EU personal data? UK Information Commissioner’s Office issues draft guidance for compliance with the GDPR’s contracting requirements.

September 14, 2017| Blog| Viewpoint

The Mintz Matrix - September 2017

September 14, 2017| Blog| Viewpoint

Washington State AG Files Suit to Break Up Health System That Expanded Through Incremental Acquisitions

September 14, 2017| Blog| Viewpoint

Is Medicaid Doing All It Can To Stop Fraud?

September 14, 2017| News

But What About Food? FDA Director Scott Gottlieb’s 4-month Scorecard

September 14, 2017| News

Fall Legislative Sessions Commence; Attorney General Certifies Ballot Questions

September 14, 2017| Advisory| Viewpoint

News & Press Releases

Mintz Advises on Equillium, Inc.'s up to $50 Million PIPE

August 15, 2025

Mintz advised the lead placement agent in connection with an up to $50 million private placement by Equillium, Inc. The PIPE was comprised of (i) an initial upfront closing of approximately $30 million in gross proceeds in exchange for approximately 52.6 million shares of common stock (or, for certain investors, pre-funded warrants in lieu of common stock), and (ii) the potential for up to an additional $20 million in gross proceeds in exchange for up to approximately 35.1 million shares of common stock (or, for certain investors, pre-funded warrants in lieu of common stock), subject to achieving specified milestones related to clinical study initiation and share price.

Eleven Mintz Attorneys Named to 2025 IAM Strategy 300 List of Leading IP Strategists

August 14, 2025

Mintz announces that eleven of its attorneys have been named to the 2025 IAM Strategy 300: The World's Leading IP Strategists list, which recognizes individuals for their trailblazing work in developing and implementing strategies that maximize the value of intellectual property portfolios.

ESG-Focused Activism Persists Despite Proxy Curbs

August 12, 2025

Law360 published an article written by Mintz Members Jacob Hupart, Ellen Shapiro, and Associate Will McKitterick about the role ESG considerations continue to play in shareholder activism and proxy battles. The article also examines how recent regulatory and political developments have raised the bar for ESG-related proposals, influencing both strategy and outcomes.

View all News and Press Releases